Report Overview
This report provides a deep insight into the global Tumor Immunotherapy market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Tumor Immunotherapy Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Tumor Immunotherapy market in any manner.
Global Tumor Immunotherapy Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Roche
Merck
Novartis
Johnson & Johnson
GlaxoSmithKline
AbbVie
ELI Lilly
Amgen
AstraZeneca
Bristol-Mysers Squibb
Kite Pharma
Adaptimmune
Altor Bioscience Corporation
Cellectis
Juno Therapeutics
Takara Bio
Unum Therapeutics
Sunway
Junshi Bio
Cinda Bio
BeiGene
Market Segmentation (by Type)
Tumor Infiltrating Lymphocyte (TIL) Treatment
Engineered T Cell Receptor (TCR) Therapy
Chimeric Antigen Receptor (CAR) T Cell Therapy
Natural Killer (NK) Cell Therapy
Other
Market Segmentation (by Application)
Biopharmaceutical Company
Hospital
Universities And Other Scientific Research Institutions
Other
Geographic Segmentation
? North America (USA, Canada, Mexico)
? Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
? Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
? South America (Brazil, Argentina, Columbia, Rest of South America)
? The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
? Industry drivers, restraints, and opportunities covered in the study
? Neutral perspective on the market performance
? Recent industry trends and developments
? Competitive landscape & strategies of key players
? Potential & niche segments and regions exhibiting promising growth covered
? Historical, current, and projected market size, in terms of value
? In-depth analysis of the Tumor Immunotherapy Market
? Overview of the regional outlook of the Tumor Immunotherapy Market:
Key Reasons to Buy this Report:
? Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
? This enables you to anticipate market changes to remain ahead of your competitors
? You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
? The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
? Provision of market value (USD Billion) data for each segment and sub-segment
? Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
? Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
? Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
? Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
? The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
? Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
? Provides insight into the market through Value Chain
? Market dynamics scenario, along with growth opportunities of the market in the years to come
? 6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Tumor Immunotherapy Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
TABLE OF CONTENTS
Table of Contents
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Tumor Immunotherapy
1.2 Key Market Segments
1.2.1 Tumor Immunotherapy Segment by Type
1.2.2 Tumor Immunotherapy Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Tumor Immunotherapy Market Overview
2.1 Global Market Overview
2.1.1 Global Tumor Immunotherapy Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Tumor Immunotherapy Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Tumor Immunotherapy Market Competitive Landscape
3.1 Global Tumor Immunotherapy Sales by Manufacturers (2019-2024)
3.2 Global Tumor Immunotherapy Revenue Market Share by Manufacturers (2019-2024)
3.3 Tumor Immunotherapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Tumor Immunotherapy Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Tumor Immunotherapy Sales Sites, Area Served, Product Type
3.6 Tumor Immunotherapy Market Competitive Situation and Trends
3.6.1 Tumor Immunotherapy Market Concentration Rate
3.6.2 Global 5 and 10 Largest Tumor Immunotherapy Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Tumor Immunotherapy Industry Chain Analysis
4.1 Tumor Immunotherapy Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Tumor Immunotherapy Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Tumor Immunotherapy Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Tumor Immunotherapy Sales Market Share by Type (2019-2024)
6.3 Global Tumor Immunotherapy Market Size Market Share by Type (2019-2024)
6.4 Global Tumor Immunotherapy Price by Type (2019-2024)
7 Tumor Immunotherapy Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Tumor Immunotherapy Market Sales by Application (2019-2024)
7.3 Global Tumor Immunotherapy Market Size (M USD) by Application (2019-2024)
7.4 Global Tumor Immunotherapy Sales Growth Rate by Application (2019-2024)
8 Tumor Immunotherapy Market Segmentation by Region
8.1 Global Tumor Immunotherapy Sales by Region
8.1.1 Global Tumor Immunotherapy Sales by Region
8.1.2 Global Tumor Immunotherapy Sales Market Share by Region
8.2 North America
8.2.1 North America Tumor Immunotherapy Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Tumor Immunotherapy Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Tumor Immunotherapy Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Tumor Immunotherapy Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Tumor Immunotherapy Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Key Companies Profile
9.1 Roche
9.1.1 Roche Tumor Immunotherapy Basic Information
9.1.2 Roche Tumor Immunotherapy Product Overview
9.1.3 Roche Tumor Immunotherapy Product Market Performance
9.1.4 Roche Business Overview
9.1.5 Roche Tumor Immunotherapy SWOT Analysis
9.1.6 Roche Recent Developments
9.2 Merck
9.2.1 Merck Tumor Immunotherapy Basic Information
9.2.2 Merck Tumor Immunotherapy Product Overview
9.2.3 Merck Tumor Immunotherapy Product Market Performance
9.2.4 Merck Business Overview
9.2.5 Merck Tumor Immunotherapy SWOT Analysis
9.2.6 Merck Recent Developments
9.3 Novartis
9.3.1 Novartis Tumor Immunotherapy Basic Information
9.3.2 Novartis Tumor Immunotherapy Product Overview
9.3.3 Novartis Tumor Immunotherapy Product Market Performance
9.3.4 Novartis Tumor Immunotherapy SWOT Analysis
9.3.5 Novartis Business Overview
9.3.6 Novartis Recent Developments
9.4 Johnson and Johnson
9.4.1 Johnson and Johnson Tumor Immunotherapy Basic Information
9.4.2 Johnson and Johnson Tumor Immunotherapy Product Overview
9.4.3 Johnson and Johnson Tumor Immunotherapy Product Market Performance
9.4.4 Johnson and Johnson Business Overview
9.4.5 Johnson and Johnson Recent Developments
9.5 GlaxoSmithKline
9.5.1 GlaxoSmithKline Tumor Immunotherapy Basic Information
9.5.2 GlaxoSmithKline Tumor Immunotherapy Product Overview
9.5.3 GlaxoSmithKline Tumor Immunotherapy Product Market Performance
9.5.4 GlaxoSmithKline Business Overview
9.5.5 GlaxoSmithKline Recent Developments
9.6 AbbVie
9.6.1 AbbVie Tumor Immunotherapy Basic Information
9.6.2 AbbVie Tumor Immunotherapy Product Overview
9.6.3 AbbVie Tumor Immunotherapy Product Market Performance
9.6.4 AbbVie Business Overview
9.6.5 AbbVie Recent Developments
9.7 ELI Lilly
9.7.1 ELI Lilly Tumor Immunotherapy Basic Information
9.7.2 ELI Lilly Tumor Immunotherapy Product Overview
9.7.3 ELI Lilly Tumor Immunotherapy Product Market Performance
9.7.4 ELI Lilly Business Overview
9.7.5 ELI Lilly Recent Developments
9.8 Amgen
9.8.1 Amgen Tumor Immunotherapy Basic Information
9.8.2 Amgen Tumor Immunotherapy Product Overview
9.8.3 Amgen Tumor Immunotherapy Product Market Performance
9.8.4 Amgen Business Overview
9.8.5 Amgen Recent Developments
9.9 AstraZeneca
9.9.1 AstraZeneca Tumor Immunotherapy Basic Information
9.9.2 AstraZeneca Tumor Immunotherapy Product Overview
9.9.3 AstraZeneca Tumor Immunotherapy Product Market Performance
9.9.4 AstraZeneca Business Overview
9.9.5 AstraZeneca Recent Developments
9.10 Bristol-Mysers Squibb
9.10.1 Bristol-Mysers Squibb Tumor Immunotherapy Basic Information
9.10.2 Bristol-Mysers Squibb Tumor Immunotherapy Product Overview
9.10.3 Bristol-Mysers Squibb Tumor Immunotherapy Product Market Performance
9.10.4 Bristol-Mysers Squibb Business Overview
9.10.5 Bristol-Mysers Squibb Recent Developments
9.11 Kite Pharma
9.11.1 Kite Pharma Tumor Immunotherapy Basic Information
9.11.2 Kite Pharma Tumor Immunotherapy Product Overview
9.11.3 Kite Pharma Tumor Immunotherapy Product Market Performance
9.11.4 Kite Pharma Business Overview
9.11.5 Kite Pharma Recent Developments
9.12 Adaptimmune
9.12.1 Adaptimmune Tumor Immunotherapy Basic Information
9.12.2 Adaptimmune Tumor Immunotherapy Product Overview
9.12.3 Adaptimmune Tumor Immunotherapy Product Market Performance
9.12.4 Adaptimmune Business Overview
9.12.5 Adaptimmune Recent Developments
9.13 Altor Bioscience Corporation
9.13.1 Altor Bioscience Corporation Tumor Immunotherapy Basic Information
9.13.2 Altor Bioscience Corporation Tumor Immunotherapy Product Overview
9.13.3 Altor Bioscience Corporation Tumor Immunotherapy Product Market Performance
9.13.4 Altor Bioscience Corporation Business Overview
9.13.5 Altor Bioscience Corporation Recent Developments
9.14 Cellectis
9.14.1 Cellectis Tumor Immunotherapy Basic Information
9.14.2 Cellectis Tumor Immunotherapy Product Overview
9.14.3 Cellectis Tumor Immunotherapy Product Market Performance
9.14.4 Cellectis Business Overview
9.14.5 Cellectis Recent Developments
9.15 Juno Therapeutics
9.15.1 Juno Therapeutics Tumor Immunotherapy Basic Information
9.15.2 Juno Therapeutics Tumor Immunotherapy Product Overview
9.15.3 Juno Therapeutics Tumor Immunotherapy Product Market Performance
9.15.4 Juno Therapeutics Business Overview
9.15.5 Juno Therapeutics Recent Developments
9.16 Takara Bio
9.16.1 Takara Bio Tumor Immunotherapy Basic Information
9.16.2 Takara Bio Tumor Immunotherapy Product Overview
9.16.3 Takara Bio Tumor Immunotherapy Product Market Performance
9.16.4 Takara Bio Business Overview
9.16.5 Takara Bio Recent Developments
9.17 Unum Therapeutics
9.17.1 Unum Therapeutics Tumor Immunotherapy Basic Information
9.17.2 Unum Therapeutics Tumor Immunotherapy Product Overview
9.17.3 Unum Therapeutics Tumor Immunotherapy Product Market Performance
9.17.4 Unum Therapeutics Business Overview
9.17.5 Unum Therapeutics Recent Developments
9.18 Sunway
9.18.1 Sunway Tumor Immunotherapy Basic Information
9.18.2 Sunway Tumor Immunotherapy Product Overview
9.18.3 Sunway Tumor Immunotherapy Product Market Performance
9.18.4 Sunway Business Overview
9.18.5 Sunway Recent Developments
9.19 Junshi Bio
9.19.1 Junshi Bio Tumor Immunotherapy Basic Information
9.19.2 Junshi Bio Tumor Immunotherapy Product Overview
9.19.3 Junshi Bio Tumor Immunotherapy Product Market Performance
9.19.4 Junshi Bio Business Overview
9.19.5 Junshi Bio Recent Developments
9.20 Cinda Bio
9.20.1 Cinda Bio Tumor Immunotherapy Basic Information
9.20.2 Cinda Bio Tumor Immunotherapy Product Overview
9.20.3 Cinda Bio Tumor Immunotherapy Product Market Performance
9.20.4 Cinda Bio Business Overview
9.20.5 Cinda Bio Recent Developments
9.21 BeiGene
9.21.1 BeiGene Tumor Immunotherapy Basic Information
9.21.2 BeiGene Tumor Immunotherapy Product Overview
9.21.3 BeiGene Tumor Immunotherapy Product Market Performance
9.21.4 BeiGene Business Overview
9.21.5 BeiGene Recent Developments
10 Tumor Immunotherapy Market Forecast by Region
10.1 Global Tumor Immunotherapy Market Size Forecast
10.2 Global Tumor Immunotherapy Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Tumor Immunotherapy Market Size Forecast by Country
10.2.3 Asia Pacific Tumor Immunotherapy Market Size Forecast by Region
10.2.4 South America Tumor Immunotherapy Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Tumor Immunotherapy by Country
11 Forecast Market by Type and by Application (2025-2030)
11.1 Global Tumor Immunotherapy Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Tumor Immunotherapy by Type (2025-2030)
11.1.2 Global Tumor Immunotherapy Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Tumor Immunotherapy by Type (2025-2030)
11.2 Global Tumor Immunotherapy Market Forecast by Application (2025-2030)
11.2.1 Global Tumor Immunotherapy Sales (K Units) Forecast by Application
11.2.2 Global Tumor Immunotherapy Market Size (M USD) Forecast by Application (2025-2030)
12 Conclusion and Key Findings
LIST OF TABLES & FIGURES
List of Tables
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Tumor Immunotherapy Market Size Comparison by Region (M USD)
Table 5. Global Tumor Immunotherapy Sales (K Units) by Manufacturers (2019-2024)
Table 6. Global Tumor Immunotherapy Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Tumor Immunotherapy Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Tumor Immunotherapy Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Tumor Immunotherapy as of 2022)
Table 10. Global Market Tumor Immunotherapy Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Tumor Immunotherapy Sales Sites and Area Served
Table 12. Manufacturers Tumor Immunotherapy Product Type
Table 13. Global Tumor Immunotherapy Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Tumor Immunotherapy
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Tumor Immunotherapy Market Challenges
Table 22. Global Tumor Immunotherapy Sales by Type (K Units)
Table 23. Global Tumor Immunotherapy Market Size by Type (M USD)
Table 24. Global Tumor Immunotherapy Sales (K Units) by Type (2019-2024)
Table 25. Global Tumor Immunotherapy Sales Market Share by Type (2019-2024)
Table 26. Global Tumor Immunotherapy Market Size (M USD) by Type (2019-2024)
Table 27. Global Tumor Immunotherapy Market Size Share by Type (2019-2024)
Table 28. Global Tumor Immunotherapy Price (USD/Unit) by Type (2019-2024)
Table 29. Global Tumor Immunotherapy Sales (K Units) by Application
Table 30. Global Tumor Immunotherapy Market Size by Application
Table 31. Global Tumor Immunotherapy Sales by Application (2019-2024) & (K Units)
Table 32. Global Tumor Immunotherapy Sales Market Share by Application (2019-2024)
Table 33. Global Tumor Immunotherapy Sales by Application (2019-2024) & (M USD)
Table 34. Global Tumor Immunotherapy Market Share by Application (2019-2024)
Table 35. Global Tumor Immunotherapy Sales Growth Rate by Application (2019-2024)
Table 36. Global Tumor Immunotherapy Sales by Region (2019-2024) & (K Units)
Table 37. Global Tumor Immunotherapy Sales Market Share by Region (2019-2024)
Table 38. North America Tumor Immunotherapy Sales by Country (2019-2024) & (K Units)
Table 39. Europe Tumor Immunotherapy Sales by Country (2019-2024) & (K Units)
Table 40. Asia Pacific Tumor Immunotherapy Sales by Region (2019-2024) & (K Units)
Table 41. South America Tumor Immunotherapy Sales by Country (2019-2024) & (K Units)
Table 42. Middle East and Africa Tumor Immunotherapy Sales by Region (2019-2024) & (K Units)
Table 43. Roche Tumor Immunotherapy Basic Information
Table 44. Roche Tumor Immunotherapy Product Overview
Table 45. Roche Tumor Immunotherapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 46. Roche Business Overview
Table 47. Roche Tumor Immunotherapy SWOT Analysis
Table 48. Roche Recent Developments
Table 49. Merck Tumor Immunotherapy Basic Information
Table 50. Merck Tumor Immunotherapy Product Overview
Table 51. Merck Tumor Immunotherapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 52. Merck Business Overview
Table 53. Merck Tumor Immunotherapy SWOT Analysis
Table 54. Merck Recent Developments
Table 55. Novartis Tumor Immunotherapy Basic Information
Table 56. Novartis Tumor Immunotherapy Product Overview
Table 57. Novartis Tumor Immunotherapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 58. Novartis Tumor Immunotherapy SWOT Analysis
Table 59. Novartis Business Overview
Table 60. Novartis Recent Developments
Table 61. Johnson and Johnson Tumor Immunotherapy Basic Information
Table 62. Johnson and Johnson Tumor Immunotherapy Product Overview
Table 63. Johnson and Johnson Tumor Immunotherapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 64. Johnson and Johnson Business Overview
Table 65. Johnson and Johnson Recent Developments
Table 66. GlaxoSmithKline Tumor Immunotherapy Basic Information
Table 67. GlaxoSmithKline Tumor Immunotherapy Product Overview
Table 68. GlaxoSmithKline Tumor Immunotherapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 69. GlaxoSmithKline Business Overview
Table 70. GlaxoSmithKline Recent Developments
Table 71. AbbVie Tumor Immunotherapy Basic Information
Table 72. AbbVie Tumor Immunotherapy Product Overview
Table 73. AbbVie Tumor Immunotherapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 74. AbbVie Business Overview
Table 75. AbbVie Recent Developments
Table 76. ELI Lilly Tumor Immunotherapy Basic Information
Table 77. ELI Lilly Tumor Immunotherapy Product Overview
Table 78. ELI Lilly Tumor Immunotherapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 79. ELI Lilly Business Overview
Table 80. ELI Lilly Recent Developments
Table 81. Amgen Tumor Immunotherapy Basic Information
Table 82. Amgen Tumor Immunotherapy Product Overview
Table 83. Amgen Tumor Immunotherapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 84. Amgen Business Overview
Table 85. Amgen Recent Developments
Table 86. AstraZeneca Tumor Immunotherapy Basic Information
Table 87. AstraZeneca Tumor Immunotherapy Product Overview
Table 88. AstraZeneca Tumor Immunotherapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 89. AstraZeneca Business Overview
Table 90. AstraZeneca Recent Developments
Table 91. Bristol-Mysers Squibb Tumor Immunotherapy Basic Information
Table 92. Bristol-Mysers Squibb Tumor Immunotherapy Product Overview
Table 93. Bristol-Mysers Squibb Tumor Immunotherapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 94. Bristol-Mysers Squibb Business Overview
Table 95. Bristol-Mysers Squibb Recent Developments
Table 96. Kite Pharma Tumor Immunotherapy Basic Information
Table 97. Kite Pharma Tumor Immunotherapy Product Overview
Table 98. Kite Pharma Tumor Immunotherapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 99. Kite Pharma Business Overview
Table 100. Kite Pharma Recent Developments
Table 101. Adaptimmune Tumor Immunotherapy Basic Information
Table 102. Adaptimmune Tumor Immunotherapy Product Overview
Table 103. Adaptimmune Tumor Immunotherapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 104. Adaptimmune Business Overview
Table 105. Adaptimmune Recent Developments
Table 106. Altor Bioscience Corporation Tumor Immunotherapy Basic Information
Table 107. Altor Bioscience Corporation Tumor Immunotherapy Product Overview
Table 108. Altor Bioscience Corporation Tumor Immunotherapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 109. Altor Bioscience Corporation Business Overview
Table 110. Altor Bioscience Corporation Recent Developments
Table 111. Cellectis Tumor Immunotherapy Basic Information
Table 112. Cellectis Tumor Immunotherapy Product Overview
Table 113. Cellectis Tumor Immunotherapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 114. Cellectis Business Overview
Table 115. Cellectis Recent Developments
Table 116. Juno Therapeutics Tumor Immunotherapy Basic Information
Table 117. Juno Therapeutics Tumor Immunotherapy Product Overview
Table 118. Juno Therapeutics Tumor Immunotherapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 119. Juno Therapeutics Business Overview
Table 120. Juno Therapeutics Recent Developments
Table 121. Takara Bio Tumor Immunotherapy Basic Information
Table 122. Takara Bio Tumor Immunotherapy Product Overview
Table 123. Takara Bio Tumor Immunotherapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 124. Takara Bio Business Overview
Table 125. Takara Bio Recent Developments
Table 126. Unum Therapeutics Tumor Immunotherapy Basic Information
Table 127. Unum Therapeutics Tumor Immunotherapy Product Overview
Table 128. Unum Therapeutics Tumor Immunotherapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 129. Unum Therapeutics Business Overview
Table 130. Unum Therapeutics Recent Developments
Table 131. Sunway Tumor Immunotherapy Basic Information
Table 132. Sunway Tumor Immunotherapy Product Overview
Table 133. Sunway Tumor Immunotherapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 134. Sunway Business Overview
Table 135. Sunway Recent Developments
Table 136. Junshi Bio Tumor Immunotherapy Basic Information
Table 137. Junshi Bio Tumor Immunotherapy Product Overview
Table 138. Junshi Bio Tumor Immunotherapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 139. Junshi Bio Business Overview
Table 140. Junshi Bio Recent Developments
Table 141. Cinda Bio Tumor Immunotherapy Basic Information
Table 142. Cinda Bio Tumor Immunotherapy Product Overview
Table 143. Cinda Bio Tumor Immunotherapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 144. Cinda Bio Business Overview
Table 145. Cinda Bio Recent Developments
Table 146. BeiGene Tumor Immunotherapy Basic Information
Table 147. BeiGene Tumor Immunotherapy Product Overview
Table 148. BeiGene Tumor Immunotherapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 149. BeiGene Business Overview
Table 150. BeiGene Recent Developments
Table 151. Global Tumor Immunotherapy Sales Forecast by Region (2025-2030) & (K Units)
Table 152. Global Tumor Immunotherapy Market Size Forecast by Region (2025-2030) & (M USD)
Table 153. North America Tumor Immunotherapy Sales Forecast by Country (2025-2030) & (K Units)
Table 154. North America Tumor Immunotherapy Market Size Forecast by Country (2025-2030) & (M USD)
Table 155. Europe Tumor Immunotherapy Sales Forecast by Country (2025-2030) & (K Units)
Table 156. Europe Tumor Immunotherapy Market Size Forecast by Country (2025-2030) & (M USD)
Table 157. Asia Pacific Tumor Immunotherapy Sales Forecast by Region (2025-2030) & (K Units)
Table 158. Asia Pacific Tumor Immunotherapy Market Size Forecast by Region (2025-2030) & (M USD)
Table 159. South America Tumor Immunotherapy Sales Forecast by Country (2025-2030) & (K Units)
Table 160. South America Tumor Immunotherapy Market Size Forecast by Country (2025-2030) & (M USD)
Table 161. Middle East and Africa Tumor Immunotherapy Consumption Forecast by Country (2025-2030) & (Units)
Table 162. Middle East and Africa Tumor Immunotherapy Market Size Forecast by Country (2025-2030) & (M USD)
Table 163. Global Tumor Immunotherapy Sales Forecast by Type (2025-2030) & (K Units)
Table 164. Global Tumor Immunotherapy Market Size Forecast by Type (2025-2030) & (M USD)
Table 165. Global Tumor Immunotherapy Price Forecast by Type (2025-2030) & (USD/Unit)
Table 166. Global Tumor Immunotherapy Sales (K Units) Forecast by Application (2025-2030)
Table 167. Global Tumor Immunotherapy Market Size Forecast by Application (2025-2030) & (M USD)
List of Figures
Figure 1. Product Picture of Tumor Immunotherapy
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Tumor Immunotherapy Market Size (M USD), 2019-2030
Figure 5. Global Tumor Immunotherapy Market Size (M USD) (2019-2030)
Figure 6. Global Tumor Immunotherapy Sales (K Units) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Tumor Immunotherapy Market Size by Country (M USD)
Figure 11. Tumor Immunotherapy Sales Share by Manufacturers in 2023
Figure 12. Global Tumor Immunotherapy Revenue Share by Manufacturers in 2023
Figure 13. Tumor Immunotherapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Tumor Immunotherapy Average Price (USD/Unit) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Tumor Immunotherapy Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Tumor Immunotherapy Market Share by Type
Figure 18. Sales Market Share of Tumor Immunotherapy by Type (2019-2024)
Figure 19. Sales Market Share of Tumor Immunotherapy by Type in 2023
Figure 20. Market Size Share of Tumor Immunotherapy by Type (2019-2024)
Figure 21. Market Size Market Share of Tumor Immunotherapy by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Tumor Immunotherapy Market Share by Application
Figure 24. Global Tumor Immunotherapy Sales Market Share by Application (2019-2024)
Figure 25. Global Tumor Immunotherapy Sales Market Share by Application in 2023
Figure 26. Global Tumor Immunotherapy Market Share by Application (2019-2024)
Figure 27. Global Tumor Immunotherapy Market Share by Application in 2023
Figure 28. Global Tumor Immunotherapy Sales Growth Rate by Application (2019-2024)
Figure 29. Global Tumor Immunotherapy Sales Market Share by Region (2019-2024)
Figure 30. North America Tumor Immunotherapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 31. North America Tumor Immunotherapy Sales Market Share by Country in 2023
Figure 32. U.S. Tumor Immunotherapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 33. Canada Tumor Immunotherapy Sales (K Units) and Growth Rate (2019-2024)
Figure 34. Mexico Tumor Immunotherapy Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Tumor Immunotherapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 36. Europe Tumor Immunotherapy Sales Market Share by Country in 2023
Figure 37. Germany Tumor Immunotherapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 38. France Tumor Immunotherapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 39. U.K. Tumor Immunotherapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 40. Italy Tumor Immunotherapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 41. Russia Tumor Immunotherapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 42. Asia Pacific Tumor Immunotherapy Sales and Growth Rate (K Units)
Figure 43. Asia Pacific Tumor Immunotherapy Sales Market Share by Region in 2023
Figure 44. China Tumor Immunotherapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 45. Japan Tumor Immunotherapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 46. South Korea Tumor Immunotherapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 47. India Tumor Immunotherapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 48. Southeast Asia Tumor Immunotherapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 49. South America Tumor Immunotherapy Sales and Growth Rate (K Units)
Figure 50. South America Tumor Immunotherapy Sales Market Share by Country in 2023
Figure 51. Brazil Tumor Immunotherapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 52. Argentina Tumor Immunotherapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 53. Columbia Tumor Immunotherapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 54. Middle East and Africa Tumor Immunotherapy Sales and Growth Rate (K Units)
Figure 55. Middle East and Africa Tumor Immunotherapy Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Tumor Immunotherapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 57. UAE Tumor Immunotherapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 58. Egypt Tumor Immunotherapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 59. Nigeria Tumor Immunotherapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 60. South Africa Tumor Immunotherapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 61. Global Tumor Immunotherapy Sales Forecast by Volume (2019-2030) & (K Units)
Figure 62. Global Tumor Immunotherapy Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Tumor Immunotherapy Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Tumor Immunotherapy Market Share Forecast by Type (2025-2030)
Figure 65. Global Tumor Immunotherapy Sales Forecast by Application (2025-2030)
Figure 66. Global Tumor Immunotherapy Market Share Forecast by Application (2025-2030)
